A comparative evaluation of therapeutic efficacy and safety of Falknor’s needling versus autoimplantation in cutaneous warts

Sumir Kumar; Narvinderjeet Kaur; Balvinder Kaur Brar; Rubeena Bano; Amarbir Singh Boparai; Sukhpreet Kaur Gill

doi:10.5455/njppp.2023.13.09419202214092022

2023, Vol: 13, Issue: 5

13/5Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Natl J Physiol Pharm Pharmacol. 2023; 13(5): 904-908

doi: 10.5455/njppp.2023.13.09419202214092022

A comparative evaluation of therapeutic efficacy and safety of Falknor’s needling versus autoimplantation in cutaneous warts

Sumir Kumar, Narvinderjeet Kaur, Balvinder Kaur Brar, Rubeena Bano, Amarbir Singh Boparai, Sukhpreet Kaur Gill.

Abstract
Background: Warts, the most common manifestation caused by human papillomaviruses. Treatment is needed because of risk of transmission, cosmetic point of view, multiple, painful, and disfigurement caused by warts.

Aims and Objectives: In this study, two techniques of autologous therapy are compared in terms of safety and efficacy. Falknor’s needling and autoimplantation, both are minimally invasive procedures with the aim of treating one wart and inducing immunity against the viral infected cells.

Materials and Methods: Forty patients of clinically diagnosed cutaneous warts were randomly divided into two groups. In Group A, Falknor’s needling was performed on a single lesion in each patient. In Group B, autoimplantation was done by harvesting a single lesion and then implanting the tissue in subcutaneous tissue of the patient at other body site.

Results: Data were analyzed using SPSS software v. 23 (IBM Statistics, Chicago, USA) and Microsoft Office 2007. Both the modalities showed excellent response (P = 0.504) in the treatment of warts with Grade 4 improvement in 85% (17 patients each) in both the modalities, with 5% of the patients showing Grade 2 and Grade 3 improvement each in needling group.

Conclusion: Both the modalities of autologous therapy are simple, easy to perform, safe, and cheap modalities with excellent results in the treatment of cutaneous warts.

Key words: Autoimplantation; Cutaneous Warts; Falknor’s Needling; Treatment; Self-Immunity

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Sumir Kumar Articles by Narvinderjeet Kaur Articles by Balvinder Kaur Brar Articles by Rubeena Bano Articles by Amarbir Singh Boparai Articles by Sukhpreet Kaur Gill
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Kumar S, Kaur N, Brar BK, Bano R, Boparai AS, Gill SK. A comparative evaluation of therapeutic efficacy and safety of Falknor’s needling versus autoimplantation in cutaneous warts. Natl J Physiol Pharm Pharmacol. 2023; 13(5): 904-908. doi:10.5455/njppp.2023.13.09419202214092022

Web Style

Kumar S, Kaur N, Brar BK, Bano R, Boparai AS, Gill SK. A comparative evaluation of therapeutic efficacy and safety of Falknor’s needling versus autoimplantation in cutaneous warts. https://www.njppp.com/?mno=63813 [Access: May 01, 2023]. doi:10.5455/njppp.2023.13.09419202214092022

AMA (American Medical Association) Style

Kumar S, Kaur N, Brar BK, Bano R, Boparai AS, Gill SK. A comparative evaluation of therapeutic efficacy and safety of Falknor’s needling versus autoimplantation in cutaneous warts. Natl J Physiol Pharm Pharmacol. 2023; 13(5): 904-908. doi:10.5455/njppp.2023.13.09419202214092022

Vancouver/ICMJE Style

Kumar S, Kaur N, Brar BK, Bano R, Boparai AS, Gill SK. A comparative evaluation of therapeutic efficacy and safety of Falknor’s needling versus autoimplantation in cutaneous warts. Natl J Physiol Pharm Pharmacol. (2023), [cited May 01, 2023]; 13(5): 904-908. doi:10.5455/njppp.2023.13.09419202214092022

Harvard Style

Kumar, S., Kaur, . N., Brar, . B. K., Bano, . R., Boparai, . A. S. & Gill, . S. K. (2023) A comparative evaluation of therapeutic efficacy and safety of Falknor’s needling versus autoimplantation in cutaneous warts. Natl J Physiol Pharm Pharmacol, 13 (5), 904-908. doi:10.5455/njppp.2023.13.09419202214092022

Turabian Style

Kumar, Sumir, Narvinderjeet Kaur, Balvinder Kaur Brar, Rubeena Bano, Amarbir Singh Boparai, and Sukhpreet Kaur Gill. 2023. A comparative evaluation of therapeutic efficacy and safety of Falknor’s needling versus autoimplantation in cutaneous warts. National Journal of Physiology, Pharmacy and Pharmacology, 13 (5), 904-908. doi:10.5455/njppp.2023.13.09419202214092022

Chicago Style

Kumar, Sumir, Narvinderjeet Kaur, Balvinder Kaur Brar, Rubeena Bano, Amarbir Singh Boparai, and Sukhpreet Kaur Gill. "A comparative evaluation of therapeutic efficacy and safety of Falknor’s needling versus autoimplantation in cutaneous warts." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 904-908. doi:10.5455/njppp.2023.13.09419202214092022

MLA (The Modern Language Association) Style

Kumar, Sumir, Narvinderjeet Kaur, Balvinder Kaur Brar, Rubeena Bano, Amarbir Singh Boparai, and Sukhpreet Kaur Gill. "A comparative evaluation of therapeutic efficacy and safety of Falknor’s needling versus autoimplantation in cutaneous warts." National Journal of Physiology, Pharmacy and Pharmacology 13.5 (2023), 904-908. Print. doi:10.5455/njppp.2023.13.09419202214092022

APA (American Psychological Association) Style

Kumar, S., Kaur, . N., Brar, . B. K., Bano, . R., Boparai, . A. S. & Gill, . S. K. (2023) A comparative evaluation of therapeutic efficacy and safety of Falknor’s needling versus autoimplantation in cutaneous warts. National Journal of Physiology, Pharmacy and Pharmacology, 13 (5), 904-908. doi:10.5455/njppp.2023.13.09419202214092022

Author Login Reviewer Login About Publisher Editorial Policies Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information



Copyright © 2023 National Journal of Physiology, Pharmacy and Pharmacology All Rights Reserved. Subject to change without notice from or liability to National Journal of Physiology, Pharmacy and Pharmacology. For best results, please use Internet Explorer or Google Chrome	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272

Contact Information

How to cite this article